Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. Dec. 6, 2017. Enno Siemsen.

Executive Summary

Check out what University of Wisconsin-Madison professor Enno Siemsen had to say about repeat facility visits from US FDA investigators after a study found that a device-maker's recall hazard increases 21% when it's inspected a second time by the same auditor.

"Investigators do develop ties with the people at the plant, and the moment that happens, they become less adversarial and don’t ask the right questions anymore. And they don’t provide the right feedback anymore, which means one of the key mechanisms of how they function is basically not there anymore." – Enno Siemsen, professor, University of Wisconsin-Madison

> Find out more: BFFs With FDA? Repeat Visits From Investigators Can Lead To Poor Device Quality, Recalls, Study Suggests

Click here for a free trial of Medtech Insight

Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT121871

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel